SK Chemicals' natural osteoarthritis treatment 'Joins' achieves cumulative sales of 500 billion KRW

Jeon Gwang-hyun, President of SK Chemicals (fifth from the left), and employees are celebrating the cumulative sales of 500 billion KRW for the natural product arthritis treatment 'Joins Tablet'.
[Photo by SK Chemicals]

[Asia Economy Reporter Lee Gwan-joo] SK Chemicals announced on the 8th that Joins Tablet, the 'No. 1 natural product drug' for osteoarthritis treatment launched in 2002, has surpassed cumulative sales of 500 billion KRW.

Joins Tablet is the first domestically developed natural product osteoarthritis treatment to exceed cumulative sales of 500 billion KRW. Over the 20 years since its launch, a total of 1.25 billion tablets have been sold, averaging more than 60 million tablets sold and consumed annually.

Joins Tablet was developed as an osteoarthritis treatment by selecting three active ingredients?Wiryungseon, Gwallugeun, and Hagocho?that reduce pain and inflammation, based on scientific evaluation and analysis of over 600 natural product components. Starting from the principles of Oriental medicine, which seeks homeostasis in human tissues, clinical studies confirmed that it provides pain relief effects equivalent to existing anti-inflammatory drugs while significantly reducing major side effects. According to the pharmaceutical research institute Ubist, Joins Tablet recorded sales of 45 billion KRW last year, ranking first in sales among natural product drugs marketed domestically.

SK Chemicals plans to continue its growth trend this year through sustained marketing efforts. Jeon Gwang-hyun, President of SK Chemicals, stated, "Joins Tablet is a representative natural product drug whose efficacy and safety have been verified through 20 years of prescription data. As the aging society rapidly approaches, we will strengthen our osteoarthritis treatment portfolio to contribute to improving the quality of life for arthritis patients."

This content was produced with the assistance of AI translation services.